"The double-digit weight reduction seen after 42 weeks of petrelintide treatment, along with rates of adverse events generally at or below the rates observed with placebo, highlight the potential of this novel amylin agonist as a future first-choice therapy for chronic weight management, said David Kendall, Chief Medical Officer of Zealand Pharma
Managing Pain Relief While Using Saxenda For patients using Saxenda who require occasional pain relief, several strategies can help minimise potential risks whilst ensuring adequate symptom control
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients
One 2026 case series described a sublingual product combining enclomiphene with boron, vitamin C and spermidine in a proprietary delivery system, which is not the compound any trial evaluated.
The treatment typically starts at a low dose, gradually increasing as guided by the physician
When used for weight loss you should eat smaller meals, increase water intake, decrease fatty and processed food and exercise